SCHEMBL25244347

SCHEMBL25244347

Fc1cc(F)c2[nH]cc(C3CNC3)c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.49
CHRNB2 P17787 5/20 0.42
CHRNA4 P43681 5/20 0.42
CHRNB4 P30926 4/20 0.42
CHRNA3 P32297 4/20 0.42
SLC6A4 P31645 7/20 0.37
AR P10275 1/20 0.37
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HTR2A P28223 2/20 0.33
HTR1A P08908 1/20 0.33
DRD1 P21728 1/20 0.33
SLC6A2 P23975 1/20 0.33
HTR1B P28222 1/20 0.33
SLC6A3 Q01959 1/20 0.33
IKBKB O14920 2/20 0.33
CHUK O15111 1/20 0.33
CSF1R P07333 1/20 0.33
BTK Q06187 1/20 0.33
CHRNA7 P36544 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25253204 0.78 SLC6A4 (0.57) GPR84CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL30877205 0.75 KDM4E (0.52) GPR84SLC6A4HTR1AHTR1BAPP
SCHEMBL30877313 0.73 KDM4E (0.44) GPR84SLC6A4HTR2AAPP
SCHEMBL31295173 0.70 HTR2A (0.59) GPR84CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL21624123 0.70 SLC6A4 (0.42) GPR84SLC6A4HTR2AHTR1ADRD1
SCHEMBL25247025 0.70 CHRNB2 (0.42) CHRNB2CHRNA4CHRNB4CHRNA3SLC6A4
SCHEMBL25245546 0.68 HTR2C (0.36) CHRNB2CHRNA4SLC6A4HTR2AIKBKB
SCHEMBL25293329 0.68 CHRNB2 (0.36) CHRNB2CHRNA4SLC6A4SLC6A2SLC6A3
SCHEMBL25245272 0.68 CHRNB2 (0.40) CHRNB2CHRNA4SLC6A4HTR2AIKBKB
SCHEMBL22688651 0.67 GPR84 (0.58) GPR84SLC6A4ARALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4447954-A1 HETEROCYCLIC COMPOUNDS AS 5HT2A BIASED AGONISTS Icahn School of Medicine at Mount Sinai (US) 2024-10-23 EP disclosed
WO-2023114472-A1 HETEROCYCLIC COMPOUNDS AS 5HT2A BIASED AGONISTS ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2023-06-22 WO disclosed
WO-2023114472-A1 HETEROCYCLIC COMPOUNDS AS 5HT2A BIASED AGONISTS ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2023-06-22 WO disclosed